Immunitas Therapeutics (United States)

Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion

Chris J. Frangieh, Johannes C. Melms, Pratiksha I. Thakore et al. · Nature Genetics · 2021 · 270 citations · Full text

Medicine, Cancer Biology, Oncology +16

Clonally expanded, GPR15-expressing pathogenic effector T _H 2 cells are associated with eosinophilic esophagitis

Duncan M. Morgan, Bert Ruiter, Neal P. Smith et al. · Science Immunology · 2021 · 114 citations · Full text

Life Sciences, Immunology, Pathology +17

Methionine Enkephalin (MENK) Inhibits tumor growth through regulating CD4+Foxp3+ Regulatory T cells (Tregs) in mice

Xuan Li, Yiming Meng, Nicolas P. Plotnikoff et al. · Cancer Biology & Therapy · 2015 · 37 citations · Full text

Life Sciences, Immunology, Oncology +17

Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS

Jens Kühle, Nadia Daizadeh, Pascal Benkert et al. · Multiple Sclerosis Journal · 2021 · 35 citations · Full text

Medicine, Neurology, Pharmacotherapy +14

Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity

Simone Punt, Shruti Malu, Jodi A. McKenzie et al. · Cancer Immunology Immunotherapy · 2020 · 34 citations · Full text

Medicine, Immunology, Oncology +17